Altimmune, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Altimmune, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2011 to Q1 2024.
  • Altimmune, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$261K, a 13.6% increase year-over-year.
  • Altimmune, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $86.1M, a 51.6% increase from 2022.
  • Altimmune, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $56.8M, a 12.8% decline from 2021.
  • Altimmune, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $65.1M, a 69.5% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$261K +$41K +13.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 -$302K -$3.48M -109% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $3.18M -$31.2M -90.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $34.4M +$34.3M +35489% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $96.7K -$12.6M -99.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q1 2019 $12.7M +$12.7M +68588% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q1 2018 $18.5K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q1 2015 -$166K -$1.54M -112% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-07
Q1 2014 $1.38M +$1.44M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q1 2013 -$60.4K -$3.26M -102% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q1 2012 $3.2M +$3.19M +25015% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q1 2011 $12.8K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.